Quantcast

Latest Neuroprotection Stories

2011-12-12 10:37:31

New research in the FASEB Journal suggests that EPO poses a risk to blood vessels in the brain and body Erythropoietin or EPO might be considered a "performance enhancing" substance for athletes, but new research published online in The FASEB Journal (http://www.fasebj.org) shows that these enhancements come at a high cost--increased risk of vascular problems in the brain. According to the study, short- or long-term use of EPO raises blood pressure by constricting arteries, which reduces...

2011-12-08 07:57:27

(Ivanhoe Newswire) — Save the neurons! A new study suggests laquinimod triggers immune cells within the central nervous system produce and release brain-derived neurotrophic factor, BDNF, contributing to the repair or survival of neurons; therefore limiting brain damage. Laquinimod is an orally available synthetic compound for the treatment of relapsing-remitting multiple sclerosis. "Our data are indicative of a direct and sustained effect of laquinimod on the up-regulation of...

2011-12-06 11:21:42

Results published in the American Journal of Pathology Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS). The mechanism of action of laquinimod has not been fully elucidated, but a study published in the January 2012 issue of The American Journal of Pathology suggests that laquinimod triggers immune cells within the central nervous system to produce...

2011-10-04 05:54:10

(Ivanhoe Newswire) — Huntington´s disease is a devastating genetic disorder that causes degeneration of nerve cells in the brain. It affects more than 15,000 Americans, and at least 150,000 are at risk of developing the incurable disease.  Now, researchers have identified a transcriptional biomarker that may help in the monitoring of disease activity and in the evaluation of new medications. The research, which is a collaboration between the laboratory of Clemens Scherzer,...

2011-09-29 09:29:21

A commonly used supplement is likely to improve outcomes and recovery for individuals who sustain a spinal cord injury (SCI), according to research conducted by University of Kentucky neuroscientists. Sasha Rabchevsky, associate professor of physiology, Patrick Sullivan, associate professor of anatomy and neurobiology, and Samir Patel, senior research scientist -- all of the UK Spinal Cord and Brain Injury Research Center (SCoBIRC) -- have discovered that in experimental models, severe...

2011-08-25 12:28:00

A diet rich in omega-3s reduces the severity of brain damage after a stroke, according to a study conducted by Université Laval researchers. The team, co-directed by professors Jasna Kriz and Frédéric Calon, showed that the extent of brain damage following a stroke was reduced by 25% in mice that consumed DHA type omega-3s daily. Details of the study can be found on the website of the journal Stroke. Researchers observed that the effects of stroke...

2011-08-17 12:16:52

Findings could be used to develop treatments to protect other nerve cell types responsible for speech and movement Neuroscientists have identified a natural protection mechanism in some of the brain's nerve cells during the onset of stroke. The findings, published today [17 August] in the Journal of Neuroscience, could be used to develop treatments to protect other nerve cell types responsible for speech and movement. Stroke "” the third largest cause of death in the UK "” causes...

2011-07-14 07:02:00

ROCKVILLE, Md., July 14, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: "Compositions to Effect Neuronal Growth." The patents cover three new compounds and include both structure and method claims for inducing neurogenesis and the growth of new neurons, both in-vitro and in-vivo. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) Neuralstem's first...

2011-06-27 21:00:00

SINGAPORE, June 27, 2011 /PRNewswire-Asia/ -- In June 2011, "Neuropharmacology" published a paper establishing NeuroAiD's reparative effects on global cerebral ischemia. Global cerebral ischemia is subsequent to cardiac arrest, reversible severe hypotension or other situations depriving the brain of oxygen and glucose. It results in residual neurologic deficits, ranging from mild cognitive impairment to severe neurological deficits, for which there is no treatment to date. The research...

2011-05-16 14:34:20

A protective molecule has been identified in the brain which, if used artificially, may prevent brain damage from the likes of stroke, head injury and Alzheimer's. By looking at what happens in the brain after an injury, new research has finally ended speculation over whether a key molecule, 'KCC2' causes brain cell death after an injury or prevents it. The finding, published today (16th May 2011) in The Journal of Physiology now opens the door to the development of artificial forms of the...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related